Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3014% above fair value
$24.73−1.44 (-5.50%)
Close on Nov 20, 2026Market cap $7.63BP/E 17.7Yield –
Oscar Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Oscar Health's free cash flow for the twelve months ending Jun 30, 2026 was $4.38B, up 264.5% year over year. For fiscal 2025 it was $1.06B, up 11.4% from the year before. The highest annual figure on record is $1.06B in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | +11.4% |
| FY2024 | Dec 31, 2024 | $950.30M | – |
| FY2023 | Dec 31, 2023 | -$297.74M | -184.7% |
| FY2022 | Dec 31, 2022 | $351.34M | – |
| FY2021 | Dec 31, 2021 | -$207.63M | -199.5% |
| FY2020 | Dec 31, 2020 | $208.71M | – |
| FY2019 | Dec 31, 2019 | -$191.37M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.08B | +316.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.61B | +200.2% |
| Q4 FY2025 | Dec 31, 2025 | $662.84M | +95.0% |
| Q3 FY2025 | Sep 30, 2025 | -$973.67M | – |
| Q2 FY2025 | Jun 30, 2025 | $499.79M | +2.1% |
| Q1 FY2025 | Mar 31, 2025 | $869.52M | +38.4% |
| Q4 FY2024 | Dec 31, 2024 | $340.00M | +16.9% |
| Q3 FY2024 | Sep 30, 2024 | -$507.71M | – |
| Q2 FY2024 | Jun 30, 2024 | $489.59M | +206.2% |
| Q1 FY2024 | Mar 31, 2024 | $628.41M | +54.3% |
| Q4 FY2023 | Dec 31, 2023 | $290.77M | +101.6% |
| Q3 FY2023 | Sep 30, 2023 | -$1.16B | – |
| Q2 FY2023 | Jun 30, 2023 | $159.91M | -23.3% |
| Q1 FY2023 | Mar 31, 2023 | $407.34M | -26.8% |
| Q4 FY2022 | Dec 31, 2022 | $144.26M | +429.0% |
| Q3 FY2022 | Sep 30, 2022 | -$557.98M | – |
| Q2 FY2022 | Jun 30, 2022 | $208.45M | +322.1% |
| Q1 FY2022 | Mar 31, 2022 | $556.60M | +78.9% |
| Q4 FY2021 | Dec 31, 2021 | $27.27M | -68.2% |
| Q3 FY2021 | Sep 30, 2021 | -$595.40M | – |
| Q2 FY2021 | Jun 30, 2021 | $49.39M | -79.6% |
| Q1 FY2021 | Mar 31, 2021 | $311.11M | +203.9% |
| Q4 FY2020 | Dec 31, 2020 | $85.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$221.75M | – |
| Q2 FY2020 | Jun 30, 2020 | $242.43M | – |
| Q1 FY2020 | Mar 31, 2020 | $102.37M | – |
See a number that looks wrong?